Injectable tranexamic acid: serious adverse reactions when inadvertently administered intrathecally/imminent Direct Healthcare Professional Communication (DHPC) submission
For the full text of the announcement click here.
For the text, as published on the website of the European Medicines Agency (EMA), please visit: //www.ema.europa.eu/
